查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612238

人工授精市场：按产品类型、捐赠者类型、技术、最终用户划分 - 全球预测 2025-2030

Artificial Insemination Market by Product (Accessories, Home Conception Devices, Insemination Kits), Donor Type (Fresh Donor Semen, Frozen Donor Semen), Technique, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年人工授精市场价值为31.7亿美元，预计到2024年将达到34.2亿美元，复合年增长率为8.16%，到2030年将达到54.9亿美元。

人工授精（AI）是生殖医学和动物繁殖中的重要技术，涉及将精液有意引入女性生殖道。这种方法不需要自然繁殖，提高了繁殖效率和遗传多样性。需要人工智慧的主要原因是整个畜牧业的遗传改良、提高繁殖成功率和疾病控制。它已广泛应用于牛、猪、家禽，最近又应用于水产养殖。在人类领域，人工智慧已成为不孕症治疗的重要解决方案。人工智慧的最终用途包括寻求有效生殖方法的农业公司到提供辅助生殖技术的医疗机构。就市场洞察而言，人工智慧市场的成长受到技术进步、不孕症现象的增加以及肉类和酪农生产需求不断增长的显着影响。人们对动物健康和生殖品质的认识不断提高，从而提高了收养率。然而，道德问题、先进技术的高成本以及跨地区监管标准不匹配等挑战可能会阻碍市场扩张。人工智慧应用在新兴经济体的扩展以及低温保存和基因检测等人工智慧技术的使用可以显着改善结果和采用率，创造潜在的商机。专注于开发适合小型农场的低成本、高效的人工智慧解决方案可以刺激需求，特别是在开发中国家。在技​​术创新方面，企业可以专注于改善人工智慧技术，提高精液分析和沈淀技术的准确性，确保更高的成功率。此外，整合人工智慧和物联网等数位解决方案可增强对育种记录和动物健康的监控和维护，推动市场迈向智慧农业和精准医疗。总体而言，市场呈现出动态特征，在潜在的社会经济和监管挑战中，技术进步和育种方法全球化方面存在巨大的成长机会。

主要市场统计
基准年[2023] 31.7亿美元
预计年份 [2024] 34.2亿美元
预测年份 [2030] 54.9亿美元
复合年增长率（%） 8.16%

市场动态：揭示快速发展的人工授精市场的关键市场洞察

供需的动态交互作用正在改变人工授精市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地的男性不孕症正在增加，导致怀孕变得困难。
    • 扩大世界各地的生育诊所和医院
    • 政府努力改善生殖健康并扩大生育治疗的机会
  • 市场限制因素
    • 进行人工授精的复杂性和缺乏熟练人员
  • 市场机会
    • 提高人工授精程序准确性和成功率的进展
    • 核准家庭不孕症套件和新的人工授精解决方案
  • 市场挑战
    • 人工授精的伦理问题与安全问题

波特五力：驾驭人工授精市场的策略工具

波特的五力架构是了解人工授精市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更具弹性的市场定位。

PESTLE分析：了解人工授精市场的外部影响

外部宏观环境因素对人工授精市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解人工授精市场的竞争状况

对人工授精市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人工授精市场厂商绩效评估

FPNV定位矩阵是评估人工授精市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了人工授精市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，人工授精市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的男性不孕症正在增加，导致怀孕变得困难。
      • 生育诊所和医院正在世界各地扩张
      • 政府努力改善生殖健康并扩大人工授精的机会
    • 抑制因素
      • 进行人工授精的复杂性和缺乏熟练人员
    • 机会
      • 提高人工授精程序准确性和成功率的进展
      • 核准家庭不孕症套件和新的人工授精解决方案
    • 任务
      • 与人工授精相关的伦理问题与安全问题
  • 市场区隔分析
    • 产品：家用施肥装置越来越受欢迎，因为它们提供更大的舒适度和便利性
    • 捐赠者类型：改善冷冻捐赠者精液储存条件和保存性的进展
    • 技术：持续研究以提高宫内授精成功率
    • 服务供应商：IVF 中心提供丰富的生育服务和患者照护的能力。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人工授精市场：副产品

  • 配件
  • 居家受孕装置
  • 人工授精套件

第七章依捐赠者类型分類的人工授精市场

  • 新鲜捐赠精液
  • 冷冻精液

第八章人工授精市场：依技术分类

  • 子宫颈内人工授精
  • 输卵管内授精
  • 子宫内人工授精
  • 阴道内人工授精

第九章人工授精市场：依最终用户分类

  • 妇科门诊
  • 医院
  • 体外受精中心
  • 妇产科医院

第十章美洲人工授精市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区人工授精市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲人工授精市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Mosie Baby 家用人工授精套件首次获得 510(k)核准
    • Femasys Inc. 的创新不孕症治疗解决方案「FemaSeed」获得美国FDA 上市批准
  • 战略分析和建议

公司名单

  • Conceivex Inc.
  • Femasys Inc.
  • Fujifilm Irvine Scientific
  • Hamilton Thorne
  • IMV Technologies
  • INVO Bioscience
  • Mosie Baby
  • Pride Angel
  • Rinovum Women's Health Company
  • Vitrolife AB
Product Code: MRR-A37FCEE11759

The Artificial Insemination Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 8.16%, to USD 5.49 billion by 2030.

Artificial insemination (AI) is a significant technology in reproductive medicine and animal breeding, involving the deliberate introduction of semen into a female's reproductive tract. This method increases reproductive efficiency and genetic diversity without requiring natural mating. AI is necessitated primarily by the need for genetic improvement, increased reproductive success, and disease control across livestock industries. It is applied significantly in cattle, swine, poultry, and increasingly in aquaculture. In the human context, AI serves as a crucial solution for infertility treatments. The end-use scope of AI spans from agricultural enterprises seeking efficient breeding practices to healthcare facilities providing assisted reproductive techniques. As for market insights, the AI market growth is heavily influenced by technological advancements, rising incidences of infertility, and growing demands in meat and dairy production. There's an upsurge in awareness about animal health and breeding quality, fueling adoption rates. However, challenges such as ethical concerns, high costs of advanced technology, and inconsistent regulatory standards across regions can impede market expansion. Potential opportunities arise from expanding AI applications in emerging economies and leveraging AI techniques like cryopreservation and genetic testing, which can significantly enhance outcomes and adoption rates. Emphasis on developing low-cost, efficient AI solutions tailored for small-scale farms can spur demand, particularly in developing nations. For innovation, businesses can focus on improving AI technologies to increase accuracy in semen analysis and deposition techniques, ensuring higher success rates. Furthermore, integrating digital solutions like AI and IoT can enhance monitoring and maintenance of breeding records and animal health, pushing the market towards smart farming and precision medicine. Overall, the market exhibits a dynamic nature with opportunities for substantial growth in technological advancements and globalization of breeding practices amidst underlying socio-economic and regulatory challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 8.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Insemination Market

The Artificial Insemination Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of male fertility issues across the world and difficulties in conceiving
    • Expansion of fertility clinics and hospitals across the world
    • Government initiatives to improve reproductive health and expand access to artificial insemination
  • Market Restraints
    • Complexities in conducting artificial insemination and lack of skilled personnel
  • Market Opportunities
    • Advancements to improve the accuracy and success rate of artificial insemination procedures
    • Approvals for at-home fertility kits and novel artificial insemination solutions
  • Market Challenges
    • Ethical issues and safety concerns related to artificial insemination

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Insemination Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Insemination Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Insemination Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Insemination Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Insemination Market

A detailed market share analysis in the Artificial Insemination Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Insemination Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Insemination Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Insemination Market

A strategic analysis of the Artificial Insemination Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Insemination Market, highlighting leading vendors and their innovative profiles. These include Conceivex Inc., Femasys Inc., Fujifilm Irvine Scientific, Hamilton Thorne, IMV Technologies, INVO Bioscience, Mosie Baby, Pride Angel, Rinovum Women's Health Company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Artificial Insemination Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Home Conception Devices, and Insemination Kits.
  • Based on Donor Type, market is studied across Fresh Donor Semen and Frozen Donor Semen.
  • Based on Technique, market is studied across Intracervical Insemination, Intratubal Insemination, Intrauterine Insemination, and Intravaginal Insemination.
  • Based on End-User, market is studied across Gynecology Clinics, Hospitals, IVF Centers, and Maternity Homes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of male fertility issues across the world and difficulties in conceiving
      • 5.1.1.2. Expansion of fertility clinics and hospitals across the world
      • 5.1.1.3. Government initiatives to improve reproductive health and expand access to artificial insemination
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in conducting artificial insemination and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements to improve the accuracy and success rate of artificial insemination procedures
      • 5.1.3.2. Approvals for at-home fertility kits and novel artificial insemination solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and safety concerns related to artificial insemination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for home conception devices to achieve higher comfort and convenience
    • 5.2.2. Donor Type: Advancements to improve storage conditions and preservation of frozen donor semen
    • 5.2.3. Technique: Ongoing research initiatives to improve the success of intrauterine insemination
    • 5.2.4. Service Provider: Ability of IVF centers to provide a plethora of fertility services and patient care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Insemination Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Home Conception Devices
  • 6.4. Insemination Kits

7. Artificial Insemination Market, by Donor Type

  • 7.1. Introduction
  • 7.2. Fresh Donor Semen
  • 7.3. Frozen Donor Semen

8. Artificial Insemination Market, by Technique

  • 8.1. Introduction
  • 8.2. Intracervical Insemination
  • 8.3. Intratubal Insemination
  • 8.4. Intrauterine Insemination
  • 8.5. Intravaginal Insemination

9. Artificial Insemination Market, by End-User

  • 9.1. Introduction
  • 9.2. Gynecology Clinics
  • 9.3. Hospitals
  • 9.4. IVF Centers
  • 9.5. Maternity Homes

10. Americas Artificial Insemination Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Insemination Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Insemination Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit
    • 13.3.2. Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Conceivex Inc.
  • 2. Femasys Inc.
  • 3. Fujifilm Irvine Scientific
  • 4. Hamilton Thorne
  • 5. IMV Technologies
  • 6. INVO Bioscience
  • 7. Mosie Baby
  • 8. Pride Angel
  • 9. Rinovum Women's Health Company
  • 10. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INSEMINATION MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INSEMINATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INSEMINATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INSEMINATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME CONCEPTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FRESH DONOR SEMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FROZEN DONOR SEMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAVAGINAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GYNECOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY IVF CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY MATERNITY HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL INSEMINATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023